Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hemodynamic Measurements in Women With Serious Preeclampsia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eldrid Langesæter, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00199810
First received: September 15, 2005
Last updated: October 14, 2016
Last verified: October 2016
  Purpose
This trial is examining hemodynamic measurements in women with serious preeclampsia.

Condition Phase
Preeclampsia
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hemodynamic Measurements in Women With Serious Preeclampsia

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Hemodynamic variations in preeclamptic women [ Time Frame: days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Urine output [ Time Frame: days ] [ Designated as safety issue: No ]
  • thrombocyte count [ Time Frame: days ] [ Designated as safety issue: No ]

Enrollment: 68
Study Start Date: July 2005
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women with moderate-to-severe pre-eclampsia
Criteria

Inclusion Criteria:

  • Women with serious preeclampsia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00199810

Locations
Norway
Oslo University Hospital
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Eldrid Langesæter Langesæter Oslo University Hospital Rikshospitalet
  More Information

Responsible Party: Eldrid Langesæter, Consultant, MD, PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT00199810     History of Changes
Other Study ID Numbers: Elangepreeklampsi2005-  S-05173 
Study First Received: September 15, 2005
Last Updated: October 14, 2016
Health Authority: Norway: Norwegian Medicines Agency

Keywords provided by Oslo University Hospital:
Cardiac output
Preeclamptic women
systemic vascular resistance
blood pressure

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on December 02, 2016